WHO ICTRP trial
Study to compare two methods of treatment to prevent active tuberculosis (TB) in…
ISRCTN53253537 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN53253537 |
|---|---|
| Public title | Study to compare two methods of treatment to prevent active tuberculosis (TB) in children |
| Scientific title | A randomized trial to compare completion and tolerability of 4 months rifampin (4 Rif) and 9 months isoniazid (9 INH) in treatment of latent TB in children |
| Primary sponsor | Canadian Institutes of Health Research (Canada) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Australia;Benin;Brazil;Canada;Ghana;Guinea;Indonesia;Saudi Arabia |
| Conditions | Tuberculosis Infections and Infestations Tuberculosis |
| Interventions | 1. The standard therapy will be daily self-administered INH,10-15 mg/kg/day for children (max=300mg/day) for 9 months (9INH) 2. As currently recommended vitamin B6 (pyridoxine) will be given with INH only to patients with risk factors for… |
| Registration date | Jul 29, 2011 |
| Target size | 822 |
| Secondary IDs | NCT00170209;BMC-009-07b |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: